Literature DB >> 1588209

Dupuytren's and epilepsy revisited.

M Arafa1, J Noble, S G Royle, I A Trail, J Allen.   

Abstract

The incidence of Dupuytren's disease amongst the residents of two epileptic centres was found to be 12.0% in one and 38.1% in the other. The overall incidence at the second was significantly higher than a control population (16.0%) and this difference was particularly apparent in patients over 50 years old. The distribution of the Dupuytren's disease was found to be very similar to that of non-epileptic patients. At both centres, the disease process was more severe, with an increased incidence of contractures. Drug therapy was not clearly implicated in the aetiology of this condition.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1588209     DOI: 10.1016/0266-7681(92)90095-j

Source DB:  PubMed          Journal:  J Hand Surg Br        ISSN: 0266-7681


  15 in total

1.  Can rock climbing lead to Dupuytren's disease?

Authors:  A J Logan; G Mason; J Dias; N Makwana
Journal:  Br J Sports Med       Date:  2005-09       Impact factor: 13.800

Review 2.  Clinical associations of Dupuytren's disease.

Authors:  M G Hart; G Hooper
Journal:  Postgrad Med J       Date:  2005-07       Impact factor: 2.401

3.  Dupuytren's fibroblast contractility by sphingosine-1-phosphate is mediated through non-muscle myosin II.

Authors:  Issei Komatsu; Jennifer Bond; Angelica Selim; James J Tomasek; L Scott Levin; Howard Levinson
Journal:  J Hand Surg Am       Date:  2010-10       Impact factor: 2.230

4.  Calcium-dependent signaling in Dupuytren's disease.

Authors:  Josef G Hadeed; Jennifer E Bond; M Angelica Selim; Andrew Bergeron; L Scott Levin; Howard Levinson
Journal:  Hand (N Y)       Date:  2010-12-15

Review 5.  Scientific understanding and clinical management of Dupuytren disease.

Authors:  Barbara Shih; Ardeshir Bayat
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

6.  Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology.

Authors:  Sandip Hindocha; Duncan Angus McGrouther; Ardeshir Bayat
Journal:  Hand (N Y)       Date:  2009-01-15

7.  Molecular mechanisms and treatment strategies for Dupuytren's disease.

Authors:  David B O'Gorman; Linda Vi; Bing Siang Gan
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

8.  Use and safety profile of antiepileptic drugs in Italy.

Authors:  M L Iorio; U Moretti; S Colcera; L Magro; I Meneghelli; D Motola; A L Rivolta; F Salvo; G P Velo
Journal:  Eur J Clin Pharmacol       Date:  2007-02-16       Impact factor: 2.953

9.  Dupuytren's Disease: Predicting Factors and Associated Conditions. A Single Center Questionnaire-Based Case-Control Study.

Authors:  Ilaria Morelli; Gianfranco Fraschini; Arianna E Banfi
Journal:  Arch Bone Jt Surg       Date:  2017-11

10.  Dupuytren's Disease: Review of the Current Literature.

Authors:  Morsi Khashan; Peter J Smitham; Wasim S Khan; Nicholas J Goddard
Journal:  Open Orthop J       Date:  2011-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.